FDA Inspection
QuVa Pharma, Inc.QuVa Pharma, Inc. – FDA Inspection, Apr 4, 2025
Record Details
This FDA Inspection record concerns QuVa Pharma, Inc., with an inspection on April 4, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · 259a7990-3b8e-4a0e-a0dc-9e9775b09d44
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1263856
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.165(d)Acceptance/Rejection Levels
- 21 CFR 211.56(b)Written sanitation procedures not followed
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.165(e)Test methods
Full citation text and observation details available on the Dashboard.
Other FDA inspections of QuVa Pharma, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| October 14, 2022 | OAI | Drug Quality Assurance | |
| May 31, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 30, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for QuVa Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.